Soulmates Ventures

Funding rounds backed by Soulmates Ventures.

Export CSV
Funding disclosed in full
$10.7M
Median round
$5.4M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Antiverse

Develops therapeutic antibodies for challenging disease targets using AI-driven techbio

$9.3MSeries AHealthtechUnited Kingdom
6 participantsDBWDOMiNO Venturesi&i Biotech FundInnovation Investment CapitalKadmos CapitalSoulmates Ventures
FluoSphera

Develops human-based preclinical platform for drug safety and efficacy testing

€1.2MUndisclosedBiotechSwitzerland
2 participantsIndieBio New YorkSoulmates Ventures